Valued at $13.1 billion by market cap, Cambridge, Massachusetts-based Moderna, Inc. (MRNA) operates as a clinical-stage ...

An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...

As Moderna maps out a more cautious future amid lower-than-expected sales of its current products, the company is bolstering ...

Bullish option flow detected in Moderna (MRNA) with 87,666 calls trading, 1.3x expected, and implied vol increasing over 2 points to 78.38%.

The vote by the U.S. Senate Finance Committee paves the way for the full Senate to vote to confirm him as secretary of the ...

The following is a summary of “Seroprevalence against SARS-CoV-2 after booster vaccination in a prison in Alicante (Spain),” published in the January 2025 issue of Infectious Disease by Montagud et al ...

A number of High Street chemists and private clinics sell and administer the Pfizer Covid vaccine directly to the public. The ...

With 2024 behind us, it’s important to reflect on arguably the most significant, historic and impactful year in public health ...

A newly developed vaccine against a group of viruses including SARS-CoV-2 is producing promising results in mice, part of the ...

A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...

Moderna is the only company in its peer group burning cash at an alarming rate. Click here to read more about MRNA stock and ...

Idaho Sen. Brandon Shippy proposes bill to ban mRNA vaccines until 2035 by incorrectly categorizing them as gene therapy, ...